| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new era has dawned for persons with cystic fibrosis; however many knowledge gaps exist in our efforts to improve care
|
Hadjiliadis, Denis
|
|
|
21 |
3 |
p. 383-384
|
artikel
|
| 2 |
CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay
|
Pallenberg, Sophia Theres
|
|
|
21 |
3 |
p. 442-447
|
artikel
|
| 3 |
Characteristics of electrolyte imbalance and pseudo-bartter syndrome in hospitalized cystic fibrosis children and adolescents
|
Abdul Aziz, Danish
|
|
|
21 |
3 |
p. 514-518
|
artikel
|
| 4 |
Complete CFTR gene sequencing in 5,058 individuals with cystic fibrosis informs variant-specific treatment
|
Raraigh, Karen S
|
|
|
21 |
3 |
p. 463-470
|
artikel
|
| 5 |
Constipation and cystic fibrosis. Slow movement
|
van der Doef, H.P.J.
|
|
|
21 |
3 |
p. 385-386
|
artikel
|
| 6 |
Cystic fibrosis-related diabetes (CFRD) and cognitive function in adults with cystic fibrosis
|
Chadwick, Helen K
|
|
|
21 |
3 |
p. 519-528
|
artikel
|
| 7 |
Diagnosing constipation in patients with cystic fibrosis applying ESPGHAN criteria
|
Stefano, Marina Abib
|
|
|
21 |
3 |
p. 497-501
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
21 |
3 |
p. ii
|
artikel
|
| 9 |
Elexacaftor/tezacaftor/ivacaftor for CFTR variants giving rise to diagnostic uncertainty: Personalised medicine or over-medicalisation?
|
Salvatore, Donatello
|
|
|
21 |
3 |
p. 544-548
|
artikel
|
| 10 |
Final results of the southwest German pilot study on cystic fibrosis newborn screening – Evaluation of an IRT/PAP protocol with IRT-dependent safety net
|
Sommerburg, Olaf
|
|
|
21 |
3 |
p. 422-433
|
artikel
|
| 11 |
Forewarned is forearmed: The cardiovascular time bomb in Cystic Fibrosis
|
Duckers, J.
|
|
|
21 |
3 |
p. 551-552
|
artikel
|
| 12 |
Global access to affordable CFTR modulator drugs: Time for action!
|
Zampoli, Marco
|
|
|
21 |
3 |
p. e215-e216
|
artikel
|
| 13 |
How the sweat gland reveals levels of CFTR activity
|
Wine, Jeffrey J.
|
|
|
21 |
3 |
p. 396-406
|
artikel
|
| 14 |
Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis
|
Wisniewski, Benjamin L.
|
|
|
21 |
3 |
p. e217-e220
|
artikel
|
| 15 |
Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
|
Michos, Athanasios
|
|
|
21 |
3 |
p. e184-e187
|
artikel
|
| 16 |
Impact of cross-sensitivity error correction on representative nitrogen-based multiple breath washout data from clinical trials
|
Robinson, Paul D.
|
|
|
21 |
3 |
p. e204-e207
|
artikel
|
| 17 |
Impact of Spiroware re-analysis method on multiple-breath washout outcomes in children with cystic fibrosis
|
Oestreich, Marc-Alexander
|
|
|
21 |
3 |
p. e208-e209
|
artikel
|
| 18 |
Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis
|
Marsh, Ryan
|
|
|
21 |
3 |
p. 506-513
|
artikel
|
| 19 |
Ivacaftor withdrawal syndrome: A potentially life-threatening consequence from a life-saving medication
|
Clegg, James M.
|
|
|
21 |
3 |
p. 549-550
|
artikel
|
| 20 |
Low body mass index as a barrier to lung transplant in cystic fibrosis
|
Jennerich, Ann L.
|
|
|
21 |
3 |
p. 475-481
|
artikel
|
| 21 |
Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls
|
Dellschaft, Neele S
|
|
|
21 |
3 |
p. 502-505
|
artikel
|
| 22 |
Needle-free iontophoresis-driven β-adrenergic sweat rate test
|
Reynaerts, Audrey
|
|
|
21 |
3 |
p. 407-415
|
artikel
|
| 23 |
News article
|
|
|
|
21 |
3 |
p. 379-380
|
artikel
|
| 24 |
Outcomes following lung re-transplantation in patients with cystic fibrosis
|
Chan, Ernest G.
|
|
|
21 |
3 |
p. 482-488
|
artikel
|
| 25 |
Pregnancy in cystic fibrosis: Review of the literature and expert recommendations
|
Jain, Raksha
|
|
|
21 |
3 |
p. 387-395
|
artikel
|
| 26 |
Quality of life is poorly correlated to lung disease severity in school-aged children with cystic fibrosis
|
Pattie, Phillip
|
|
|
21 |
3 |
p. e188-e203
|
artikel
|
| 27 |
Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward
|
Hatton, Aurelie
|
|
|
21 |
3 |
p. 448-455
|
artikel
|
| 28 |
Regarding the articles on home spirometry
|
Curley, Rachael
|
|
|
21 |
3 |
p. e212-e214
|
artikel
|
| 29 |
Re: Impact of spiroware re-analysis method on multiple-breath washout outcomes in children with cystic fibrosis; M.A. Oestreich, F. Wyler, P. Latzin et al.
|
Jensen, Renee
|
|
|
21 |
3 |
p. e210-e211
|
artikel
|
| 30 |
Rescue of chloride and bicarbonate transport by elexacaftor-ivacaftor-tezacaftor in organoid-derived CF intestinal and cholangiocyte monolayers
|
Bijvelds, Marcel J.C.
|
|
|
21 |
3 |
p. 537-543
|
artikel
|
| 31 |
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study
|
Meijer, Laurent
|
|
|
21 |
3 |
p. 529-536
|
artikel
|
| 32 |
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
|
Alicandro, Gianfranco
|
|
|
21 |
3 |
p. e173-e175
|
artikel
|
| 33 |
Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme
|
Cirilli, N.
|
|
|
21 |
3 |
p. 434-441
|
artikel
|
| 34 |
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
|
Martin, Clémence
|
|
|
21 |
3 |
p. 489-496
|
artikel
|
| 35 |
Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland
|
Maguire, Barrie
|
|
|
21 |
3 |
p. 416-421
|
artikel
|
| 36 |
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
|
Simonson, Joseph L.
|
|
|
21 |
3 |
p. e176-e183
|
artikel
|
| 37 |
The sweat chloride test has lived up to the changes in CF care
|
Gonska, Tanja
|
|
|
21 |
3 |
p. 381-382
|
artikel
|
| 38 |
Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population
|
Ramos, Kathleen J.
|
|
|
21 |
3 |
p. 471-474
|
artikel
|
| 39 |
Worldwide rates of diagnosis and effective treatment for cystic fibrosis
|
Guo, Jonathan
|
|
|
21 |
3 |
p. 456-462
|
artikel
|
Tijdschrift beschrijving